FI834069A - Hjaertmuskeln skyddande -butyrolaktonderivat med rytmstoerningar avlaegsnande verkan, foerfarande deras framstaellning och dessa innehaollane laekemedel - Google Patents

Hjaertmuskeln skyddande -butyrolaktonderivat med rytmstoerningar avlaegsnande verkan, foerfarande deras framstaellning och dessa innehaollane laekemedel Download PDF

Info

Publication number
FI834069A
FI834069A FI834069A FI834069A FI834069A FI 834069 A FI834069 A FI 834069A FI 834069 A FI834069 A FI 834069A FI 834069 A FI834069 A FI 834069A FI 834069 A FI834069 A FI 834069A
Authority
FI
Finland
Prior art keywords
rytmstoerningar
innehaollane
hjaertmuskeln
ceekemedel
butyrolaktonderivat
Prior art date
Application number
FI834069A
Other languages
English (en)
Other versions
FI834069A0 (fi
FI79538C (fi
FI79538B (fi
Inventor
Claude Bernhart
Werner Cautreels
Patrick Gautier
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of FI834069A0 publication Critical patent/FI834069A0/fi
Publication of FI834069A publication Critical patent/FI834069A/fi
Application granted granted Critical
Publication of FI79538B publication Critical patent/FI79538B/fi
Publication of FI79538C publication Critical patent/FI79538C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
FI834069A 1982-11-08 1983-11-07 Foerfarande foer framstaellning av hjaertmuskeln skyddande -butyrolaktonderivat med rytmstoerningar avlaegsnande verkan. FI79538C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8218705A FR2535722B1 (fr) 1982-11-08 1982-11-08 Derives de la g-butyrolactone protecteurs du myocarde presentant une activite antiarythmique, procede pour leur preparation et medicaments en contenant
FR8218705 1982-11-08

Publications (4)

Publication Number Publication Date
FI834069A0 FI834069A0 (fi) 1983-11-07
FI834069A true FI834069A (fi) 1984-05-09
FI79538B FI79538B (fi) 1989-09-29
FI79538C FI79538C (fi) 1990-01-10

Family

ID=9278999

Family Applications (1)

Application Number Title Priority Date Filing Date
FI834069A FI79538C (fi) 1982-11-08 1983-11-07 Foerfarande foer framstaellning av hjaertmuskeln skyddande -butyrolaktonderivat med rytmstoerningar avlaegsnande verkan.

Country Status (29)

Country Link
US (1) US4542134A (fi)
EP (1) EP0113600B1 (fi)
JP (1) JPS59161379A (fi)
KR (1) KR900006723B1 (fi)
AT (1) ATE28644T1 (fi)
AU (1) AU560032B2 (fi)
CA (1) CA1224467A (fi)
CS (1) CS244680B2 (fi)
DD (2) DD220313A5 (fi)
DE (1) DE3372767D1 (fi)
DK (1) DK503683A (fi)
ES (1) ES8406071A1 (fi)
FI (1) FI79538C (fi)
FR (1) FR2535722B1 (fi)
GR (1) GR78746B (fi)
HU (1) HU192825B (fi)
IE (1) IE56208B1 (fi)
IL (1) IL70062A (fi)
MA (1) MA19947A1 (fi)
NO (1) NO159853C (fi)
NZ (1) NZ206176A (fi)
OA (1) OA07581A (fi)
PH (1) PH19547A (fi)
PL (2) PL139945B1 (fi)
PT (1) PT77606B (fi)
SG (1) SG2389G (fi)
SU (1) SU1279529A3 (fi)
YU (2) YU220483A (fi)
ZA (1) ZA837935B (fi)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714173A (en) * 1971-07-06 1973-01-30 Smith Kline French Lab Pyridyl ketipate lactones and derivatives
FR2467200A1 (fr) * 1979-10-11 1981-04-17 Clin Midy Derives du pyrrole actifs sur les troubles du rythme cardiovasculaire

Also Published As

Publication number Publication date
IL70062A (en) 1987-02-27
IE832580L (en) 1984-05-08
KR840006646A (ko) 1984-12-01
DD231567A5 (de) 1986-01-02
ZA837935B (en) 1984-06-27
PH19547A (en) 1986-05-20
PL244461A1 (en) 1985-01-30
OA07581A (fr) 1985-03-31
FI834069A0 (fi) 1983-11-07
PL142949B1 (en) 1987-12-31
DK503683D0 (da) 1983-11-03
ATE28644T1 (de) 1987-08-15
ES527092A0 (es) 1984-07-01
FI79538C (fi) 1990-01-10
HU192825B (en) 1987-07-28
NZ206176A (en) 1985-12-13
FR2535722B1 (fr) 1985-06-28
PT77606B (fr) 1986-03-18
EP0113600B1 (fr) 1987-07-29
EP0113600A1 (fr) 1984-07-18
CS821983A2 (en) 1985-10-16
DK503683A (da) 1984-05-09
JPS59161379A (ja) 1984-09-12
CA1224467A (en) 1987-07-21
MA19947A1 (fr) 1984-07-01
AU2063983A (en) 1984-05-17
DE3372767D1 (en) 1987-09-03
PL249775A1 (en) 1985-05-07
US4542134A (en) 1985-09-17
SU1279529A1 (ru) 1986-12-23
DD220313A5 (de) 1985-03-27
CS244680B2 (en) 1986-08-14
PT77606A (fr) 1983-12-01
FI79538B (fi) 1989-09-29
KR900006723B1 (ko) 1990-09-20
NO159853B (no) 1988-11-07
PL139945B1 (en) 1987-03-31
FR2535722A1 (fr) 1984-05-11
IE56208B1 (en) 1991-05-22
AU560032B2 (en) 1987-03-26
NO834053L (no) 1984-05-09
SU1279529A3 (ru) 1986-12-23
NO159853C (no) 1989-02-15
IL70062A0 (en) 1984-01-31
YU220483A (en) 1986-04-30
YU143585A (en) 1986-04-30
GR78746B (fi) 1984-10-02
SG2389G (en) 1991-01-04
ES8406071A1 (es) 1984-07-01

Similar Documents

Publication Publication Date Title
DE3363244D1 (en) Compounds, process for their preparation and their use as pharmaceutical preparations
SE7905402L (sv) Fenyl-piperazinderivat
MY100095A (en) 2-oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition.
ES443912A1 (es) Procedimiento para preparar derivados del acido fenil-aceti-co.
FI834087A0 (fi) Piperidindionderivat med myokardisk skyddsverkan samt med rytmstoerningar bekaempande verkan, derasframstaellningsfoerfarande och naemnda derivat innehaollande laekemedel
ATE27806T1 (de) Norbornan- und norbornencarbonsaeureamide und verfahren zu deren herstellung.
FI834069A (fi) Hjaertmuskeln skyddande -butyrolaktonderivat med rytmstoerningar avlaegsnande verkan, foerfarande deras framstaellning och dessa innehaollane laekemedel
SE8505369L (sv) Nya tienopyridinderivat, ett forfarande for framstellning derav och terapeutiska kompositioner innehallande dem
HUT61967A (en) Process for producing new alkyl aminoalkyl amine- and -ether derivatives and pharmaceutical compositions comprising such compounds
ATE15667T1 (de) Neue substituierte 3,5-diamino-1,2,4-oxadiazole und 3,5-diamino-1,2,4-thiadiazole, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
SE7901707L (sv) 2-betoxibensamider

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SANOFI